Skip to main content
. 2017 May;14(2):162–175. doi: 10.20892/j.issn.2095-3941.2017.0020

2.

Genotype and allele of ApaI, VDR-polymorphism, and BsmI-ApaI, ApaI-TaqI, BsmI-ApaI-TaqI combined genotypes of 74 melanoma patients and comparisons between groups of 100% VDR-positive cells (n=12) vs. <100% ( n=62); over the median (>20%) VDR-positive cells (n=36) vs. below or equal the median (≤20%) (n=38); and absence of VDR-positive cell (n=15) vs. remaining cases with detected VDR expression (n=59)

VDR genotype or combined genotype All melanoma patients (n=74) 100% VDR-positive cells (n=12) <100% VDR-positive cells (n=62) P=100% vs.<100% VDR-positive >20%a VDR-positive cells (n=36) ≤20% VDR-positive cells (n=38) P>20%vs. ≤20% VDR-positive VDR absence (0% positive)(n=15) VDR presence (>0% positive)(n=59) PVDR absence vs. presence
a Over the median value of percentage (%) of cells positive for VDR protein.
ApaI genotype
AA 30 (40.5) 8 (66.7) 22 (35.5) 0.058 13 (36.1) 17 (44.7) 0.450 8 (53.3) 22 (37.3) 0.258
Aa 36 (48.6) 4 (33.3) 32 (51.6) 0.246 22 (61.1) 14 (36.8) 0.037 5 (33.3) 31 (52.5) 0.184
aa 8 (10.8) 0 (–) 8 (12.9) 0.339 1 (2.8) 7 (18.4) 0.056 2 (13.3) 6 (10.2) 0.660
A allele 96/148 (64.9) 20/24 (83.3) 76/124 (61.3) 0.038 48/72 (66.7) 48/76 (63.2) 0.655 21/30 (70.0) 75/118 (63.6) 0.509
a allele 52/148 (35.1) 4/24 (16.7) 48/124 (38.7) 0.038 24/72 (33.3) 28/76 (36.8) 0.655 9/30 (30.0) 43/118 (36.4) 0.509
BsmI-ApaI combined genotype
BBAA 23 (31.1) 5 (41.7) 18 (29.0) 0.498 9 (25.0) 14 (36.8) 0.271 6 (40.0) 17 (28.8) 0.533
BbAA 5 (6.8) 3 (25.0) 2 (3.2) 0.028 4 (11.1) 1 (2.6) 0.194 1 (6.7) 4 (6.8) 1.000
BbAa 31 (41.9) 1 (8.3) 30 (48.4) 0.010 18 (50.0) 13 (34.2) 0.169 5 (33.3) 26 (44.1) 0.452
Bbaa 2 (2.7) 0 (–) 2 (3.2) 1.000 0 (–) 2 (5.3) 0.494 0 (–) 2 (3.4) 1.000
bbAA 2 (2.7) 0 (–) 2 (3.2) 1.000 0 (–) 2 (5.3) 0.494 1 (6.7) 1 (1.7) 0.367
bbAa 5 (6.8) 3 (25.0) 2 (3.2) 0.028 4 (11.1) 1 (2.6) 0.194 0 (–) 5 (8.5) 0.576
bbaa 6 (8.1) 0 (–) 6 (9.7) 0.581 1 (2.8) 5 (13.2) 0.200 2 (13.3) 4 (6.8) 0.595
ApaI-TaqI combined genotype
AATT 4 (5.4) 0 (–) 4 (6.5) 1.000 0 (–) 4 (10.5) 0.115 3 (20.0) 1 (1.7) 0.025
AATt 14 (18.9) 6 (50.0) 8 (12.9) 0.008 9 (25.0) 5 (13.2) 0.194 4 (26.7) 10 (16.9) 0.463
AAtt 12 (16.2) 2 (16.7) 10 (16.1) 1.000 4 (11.1) 8 (21.1) 0.246 1 (6.7) 11 (18.6) 0.439
AaTT 12 (16.2) 3 (25.0) 9 (14.5) 0.399 9 (25.0) 3 (7.9) 0.046 1 (6.7) 11 (18.6) 0.439
AaTt 24 (32.4) 1 (8.3) 23 (37.1) 0.089 13 (36.1) 11 (28.9) 0.511 4 (26.7) 20 (33.9) 0.761
aaTT 8 (10.8) 0 (–) 8 (12.9) 0.339 1 (2.8) 7 (18.4) 0.056 2 (13.3) 6 (10.2) 0.660
BsmI-ApaI-TaqI combined genotype
BBAATT 1 (1.4) 0 (–) 1 (1.6) 1.000 0 (–) 1 (2.6) 1.000 1 (6.7) 0 (–) 0.203
BBAATt 10 (13.5) 3 (25.0) 7 (11.3) 0.351 5 (13.9) 5 (13.2) 1.000 4 (26.7) 6 (10.2) 0.110
BBAAtt 12 (16.2) 2 (16.7) 10 (16.1) 1.000 4 (11.1) 8 (21.1) 0.246 1 (6.7) 11 (18.6) 0.439
BbAATt 4 (5.4) 3 (25.0) 1 (1.6) 0.012 4 (11.1) 0 (–) 0.051 0 (–) 4 (6.8) 0.576
BbAATT 1 (1.4) 0 (–) 1 (1.6) 1.000 0 (–) 1 (2.6) 1.000 1 (6.7) 0 (–) 0.203
BbAaTT 7 (9.5) 0 (–) 7 (11.3) 0.590 5 (13.9) 2 (5.3) 0.255 1 (6.7) 6 (10.2) 1.000
BbAaTt 24 (32.4) 1 (8.3) 23 (37.1) 0.089 13 (36.1) 11 (28.9) 0.511 4 (26.7) 20 (33.9) 0.761
BbaaTT 2 (2.7) 0 (–) 2 (3.2) 1.000 0 (–) 2 (5.3) 0.494 0 (–) 2 (3.4) 1.000
bbAATT 2 (2.7) 0 (–) 2 (3.2) 1.000 0 (–) 2 (5.3) 0.494 1 (6.7) 1 (1.7) 0.367
bbAaTT 5 (6.8) 3 (25.0) 2 (3.2) 0.028 4 (11.1) 1 (2.6) 0.194 0 (–) 5 (8.5) 0.576
bbaaTT 6 (8.1) 0 (–) 6 (9.7) 0.581 1 (2.8) 5 (13.2) 0.200 2 (13.3) 4 (6.8) 0.595